In Brief This Week: Bruker; Abbott; Becton Dickinson; Sigma-Aldrich; DNA Genotech; Almac Group; Genomnia | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker this week said that it has amended the terms of a credit agreement with JPMorgan Chase Bank, under which the maturity date of its revolving line of credit has been extended to May 24, 2016, and the amount available under the credit facility has been expanded to $250 million. As of May 24, 2011, Bruker had outstanding borrowings under the facility of roughly $185.5 million, while the outstanding principal amount under the term loan facility totaled $105 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.